KYN
Kyntra Bio, Inc. Common Stock (KYNB) Q4 2024 Annual Earnings
KYNB·Reported March 17, 2025·After market close
Kyntra Bio, Inc. Common Stock reported Q4 2024 revenue of -$123.3M, missed analyst consensus of $24.9M by $148.2M. Diluted EPS came in at $-0.08.
Revenue
-$123.3Mmissed by $148.2M
Consensus: $24.9MDiluted EPS
$-0.08met estimate
Consensus: $-0.08
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Kyntra Bio, Inc. Common Stock's Q4 2024 earnings report.
Kyntra Bio, Inc. Common Stock (KYNB) reported Q4 2024 earnings on March 17, 2025 after market close.
Kyntra Bio, Inc. Common Stock reported revenue of -$123.3M and diluted EPS of $-0.08 for Q4 2024.
Revenue missed the consensus estimate of $24.9M by $148.2M. EPS beat the consensus estimate of $-0.08 by $0.00.
You can read the 10-K periodic report (0000950170-25-040280) directly on SEC EDGAR. The filing index links above go to sec.gov.